Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients
収録刊行物
-
- Am J Hematol
-
Am J Hematol 80 181-187, 2005